ArticleBMC cancer2025

Thyroid dysfunction as a predictor of PD- 1/PD-L1 inhibitor efficacy in advanced lung cancer.

Yanling Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.